Clinical Research Site 2

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Pulmonary Aspergillosis, Refractory IPA

Studies at this site

• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) — Stopped early